While the success of a vaccination program for infl uenza is determined, at least in part, by the immunogenicity of the circulating strain, it also depends on the level of local immunity, particularly in areas where respiratory infections are historically prevalent. During epidemics of swine origin infl uenza A (swH1N1), states in Southern Brazil exhibited outbreak characteristics that did not correlate with those of the rest of the country. Throughout the winter, the weather in these states is cold and humid, and there is a high incidence of infl uenza infections. As such, many people are vaccinated each year (1) . However, despite the administration of a high number of vaccine doses for infl uenza H1N1, cases of severe swH1N1 infections were more prevalent in these states than in the northern and Northeastern states (2) .
Enumeration of the serum titers of antibodies specifi c to the viral glycoproteins hemagglutinin (HA) and neuraminidase (NA) is a parameter frequently used to evaluate the immune response to infl uenza (3) (4) (5) . Notably, antibodies generated against these glycoproteins in response to a particular strain of infl uenza do not always guarantee protection to other closely related strains (6) (7) . Meanwhile, seroepidemiological studies indicate that there is a lack of widespread pre-existing antibodies against swH1N1 in the general population (8) (9) (10) . In addition to antibodies, T cells are also involved in the response to infl uenza viruses (3) (11) . Several studies have demonstrated that infections by, or vaccination to, specifi c infl uenza strains can induce the production of cross-reactive T cells that can potentially recognize conserved epitopes in other strains (12) . Recent studies, however, claim that this cross-reactivity does not guarantee an effi cient cross-response (11) . Furthermore, T cells that were previously induced by exposure to conserved infl uenza epitopes exhibit modest memory phenotypes and clonal expansion levels,
METHODS
compared to those of naïve cells, upon antigen stimulation (13) . Indeed, in a study of Brazilian school children, frequent exposure to seasonal infl uenza virus strains was not a relevant factor for preventing infection by swH1N1 in 2010 (14) . These fi ndings demonstrate that the relationship between previous exposures to closely related strains of the infl uenza virus and protection during an epidemic is not applicable to all situations.
To examine the effects of previous exposures to infl uenza antigens on the immune response to H1N1, we analyzed the response of lymphocytes harvested from the peripheral blood of individuals in Southern Brazil that were either vaccinated or unvaccinated against H1N1 to the post-pandemic infl uenza trivalent vaccine (Fluvac). Additionally, we determined the specifi city of the stimulation using infl uenza H1N1 major histocompatibility class I (MHC class I) conserved epitopes. These analyses were complemented by quantifi cation of the levels of interleukin 10 (IL-10) and interferon (IFN)-γ produced by cells after culturing in the presence of infl uenza antigens. The results of this study enhance our knowledge of the lymphocyte response to infl uenza in people from an endemic region, and may facilitate the development of improved protocols for infl uenza immunization and therapies.
Study population
In total, 40 healthcare professionals between the ages of 20 and 36 years were recruited for this cross-sectional study. Of these, 20 received the infl uenza vaccine during or after the 2009 H1N1 infl uenza pandemic, while the remaining 20 had never received the vaccine. Each subject completed a written inquiry regarding their health and vaccination history, and all subjects had a prior history of respiratory infection. Patients suffering from the fl u or a cold, and those exhibiting a cough or clinical signs of allergic disorders were excluded from the study.
Antigen stimulation
Fluvac vaccine formulated using the A/California/7/2009, A/Perth/16/2009, and B/Brisbane/60/2008 infl uenza strains was obtained from the Multivacin Immunization Clinic (Santa Maria, RS, Brazil). The dose used for stimulation was determined via a dose-response experiment using concentrations of 0.125, 0.25, 0.03, and 0.06µg/well. Moreover, cells were stimulated with HA and NA peptides corresponding to the amino acid sequences present in infl uenza H1N1/California/4/2009, as characterized using immunoinformatics tools (15) , which bind multiples alleles of the human leukocyte antigen (HLA) protein of humans (Table 1) . Synthetic peptides (Genemed Synthesis, Inc., San Antonio, TX, USA) were diluted in water and then in Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco, Grand Island, NY, USA). The peptide dose used for stimulation was optimized via a dose-response curve experiment using 2.5, 5.0, 10, 20, and 25µM concentrations of each of the following epitopes: HA1, LSSVSSFER; HA2, GMVDGWYGY; HA3, MESVKNGTY; NA1, VSFNQNLEY; and NA2, RPWVSFNQN. 
Isolation of peripheral blood mononuclear cells

In vitro stimulation of PBMCs
Peripheral blood mononuclear cells were stimulated in vitro with Fluvac or with HA and NA epitopes. Briefl y, 2 × 10 5 cells were cultured in flat-bottomed 96-well microplates [Techno Plastic Products (TPP) AG, Trasadingen, Switzerland] with RPMI 1640 supplemented with 10% FBS for 96 h at 37ºC in an atmosphere containing 5% CO 2 . A 1.5% concentration of the selective T cell mitogen phytohemagglutinin (PHA; Gibco) was used as a positive control, while medium alone was used as a negative control. To assess in vitro stimulation, the vaccine was diluted in RPMI and added to the cultures at a fi nal concentration of 0.125µg/well. Meanwhile, the HA and NA peptides were each added at fi nal concentrations of 5μM, as previously optimized, and the cultures were incubated at 37ºC with 5% CO 2 for 120h. For certain experiments, the cultures were also supplemented with 10 international units (IU)/well of human recombinant interleukin (IL)-2 (BD Biosciences ® , Franklin Lakes, NJ, USA). After antigen stimulation, lymphocyte viability was estimated using an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)]-based colorimetric assay (16) (Invitrogen, Carlsbad, CA, USA). The optical density at 560nm (OD 560 ) of the resulting reactions was measured using a plate reader (Thermoplate®, RS, Brazil).
Analysis of cytokine production
The concentrations of interferon (IFN)-γ, IL-10, IL-6, IL-4, and IL-2 within the culture supernatants harvested from stimulated cells were measured using a Cytometric Bead Array (CBA) Th1/ Th2 kit (BD Biosciences ® ). Because the cells from each of the 40 individuals were subjected to 10 different stimuli, we chose to pool the supernatants from those exposed to the same stimulus.
Statistical analyses
Stimulation data were analyzed by repeated measures one-way analysis of variance (ANOVA; non-stimulated vs. stimulated). Multiple comparisons between cytokine levels (PHA mitogen, vaccine, or peptides) were evaluated with Dunnett's and Tukey's post hoc tests to reduce the α error. Differences between variables were also assessed via Student's t-tests. Data were expressed as means ± standard error (SE). Statistical analyses and graphing of the results were performed using GraphPad Prims Pad 4.0 software. The signifi cance level was set at p ≤ 0.05. 
RESULTS
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HLA: human leukocyte antigen; HA: hemagglutinin; NA: neuraminidase.
Ethical considerations
The study protocol was approved by the Ethics Committee from Universidade Federal de Santa Maria, Rio Grande do Sul/ Brazil, and experiments were performed in accordance with the ethical standards of the responsible committee on human experimentation (institutional, regional, or national), and in keeping with the Helsinki Declaration of 1964, as revised in 1975, 1983, 1989, 1996 , and 2000. All subjects agreed to participate, and each participant provided informed written consent. The protocol approval number is 23081.011864/2010-8.
Analysis of the response of circulating lymphocytes from vaccinated and unvaccinated individuals to Fluvac antigens
Peripheral blood mononuclear cells from fi fteen vaccinated individuals were isolated and stimulated, as described in the Material and Methods. Because a dose-dependent increase in cell viability was not observed within a range of 0.06µg to 0.125µg ( Figure 1A ), a dosage of 0.125µg was used for all subsequent experiments. Meanwhile, the absorbance value obtained for the PHA-treated cells in the MTT assay was threefold higher than that for the unstimulated cells, indicating that this compound comprised a valid positive control ( Figure 1B) .
Next, we examined the in vitro response of PBMCs from vaccinated and unvaccinated populations to stimulation with the Fluvac vaccine. As expected, cells from the vaccinated group exhibited signifi cantly higher viability than unstimulated cells (negative control) upon treatment with Fluvac (0.562 ± 0.032 vs. 0.363 ± 0.017, respectively; p = 0.0019; Figure 1C ). While the viability of the cells from the unvaccinated group (0.471 ± 0.029) was also higher than that of the negative control cells (0.363 ± 0.017), this difference was not statistically signifi cant.
Antigen-experienced lymphocytes produced during previous infections typically increase the expression of IL-2 receptor upon re-stimulation. To examine whether cells produced in response to vaccination contribute to in vitro stimulation, we evaluated the response of cells from the vaccinated group to stimulation with Fluvac and IL-2. No signifi cant change in viability was observed in cells from the vaccinated group after treatment with IL-2, compared with that observed in cells stimulated with Fluvac alone (Figure 1D) . Similarly, while PBMCs from the unvaccinated group treated with IL-2 exhibited higher levels of stimulation than the negative control cells, this difference was not signifi cant (data not shown). Lastly, there was no difference in the level of lymphocyte stimulation obtained by exposure to Fluvac between the males and females of the vaccinated population ( Figure 1E ).
Together, these results indicate that, in the population studied, only those individuals that were vaccinated with the monovalent infl uenza post-pandemic vaccine contained blood circulating lymphocytes that could be promptly stimulated with antigens from the post-pandemic fl u vaccine.
Quantifi cation of IFN-γ and IL-10 production by lymphocytes from the vaccinated and unvaccinated populations
Evaluation of lymphocyte viability alone is not a suitable method for predicting the lymphocyte response. Therefore, to complement the MTT assay results, we evaluated the cytokine profi le induced by in vitro stimulation of PBMCs from vaccinated and unvaccinated individuals. Specifi cally, we measured the levels of helper T type 1 (Th1) [interferon gamma (IFN)-γ; interleukin-2 (IL-2); interleukin-6 (IL-6) and tumor necrosis factor (TNF)-α] and helper T type 2 (Th2) (IL-4, IL-5 and IL-10) specifi c cytokines in the supernatants from stimulated cells. There were no differences in the levels of IL-2, IL-6, TNF-α, IL-4, or IL-5 between the stimulated and negative control cells from either the vaccinated or the unvaccinated group (data not shown). Conversely, there was a dose-dependent increase in the level of IFN-γ secretion from the Fluvac-stimulated cells of the vaccinated group, compared to that observed in cells treated with media alone (negative control; Figure 2A) . Similar results were obtained using the cells of the unvaccinated group. Surprisingly, however, there were higher levels of IFN-γ in the supernatants harvested from the unvaccinated group than in those harvested from the vaccinated group after stimulation with 0.03 and 0.06µg Fluvac.
As observed for IFN-γ, cells from both the vaccinated and unvaccinated groups produced higher amounts of IL-10 in vitro than did the negative control cells after stimulation with Fluvac ( Figure 2B) . Notably, while similar levels of IFN-γ and IL-10 were produced by the cells from the vaccinated group at each dose tested (Figure 2C) , the cells in the unvaccinated group produced higher levels of IFN-γ than IL-10 at all doses tested ( Figure 2D ). These data indicate that stimulation of PBMCs from vaccinated individuals with Fluvac antigens results in a balance in the production of IL-10 and IFN-γ, which is not achieved by unprimed (unvaccinated) cells.
Determination of the specifi city of the immune response of lymphocytes from the vaccinated group
The trivalent vaccine used for the stimulation studies was composed of antigens from two strains of infl uenza A of HA and NA peptides used for stimulation was optimized by fi rst examining the effects of a range of concentrations (2.5μM to 40μM) on cell viability. As no signifi cant differences were observed among the doses tested (data not shown), a dose of 2.5μM was used for each peptide in all subsequent experiments. Cells from the vaccinated group exhibited higher levels of viability after treatment with each of the HA or NA peptides than with media alone (Figure 4A) . In contrast, neither the HA nor the NA peptides enhanced the viability of cells in the unvaccinated group compared to unstimulated cells ( Figure 4B) . The infl uence of IL-2 on the stimulation of lymphocytes was also tested for each epitope. While cells from the vaccinated group were significantly stimulated by both the HA and NA peptides in the presence of IL-2 ( Figure 4C) , there was no improvement in the stimulation index of cells from the unvaccinated group after stimulation with HA and NA in the presence of IL-2 ( Figure 4D) . These results indicate that the stimulatory response observed in PBMCs from the vaccinated group was due to the exposure of these individuals to swH1N1 cognate antigens via vaccination, and not to exposure to antigens from other infl uenza viruses. 
DISCUSSION
Despite numerous efforts to develop an effective vaccine for combating influenza infections, the disease remains a serious health problem, causing frequent epidemics. During the 2009-2011 swH1N1 pandemic, the near total absence of neutralizing antibodies within the general population should have led to a catastrophic infl uenza pandemic; however, the outcome was less devastating than originally predicted (17) . One possible explanation for this is that T cells generated in response to previous infl uenza vaccinations or infections may have provided heterosubtypic pre-immunity. Here, we demonstrated that peripheral blood lymphocytes harvested from individuals in Southern Brazil that were previously vaccinated with the swH1N1 monovalent vaccine exhibited signifi cant stimulation in vitro in response to antigens from the new trivalent vaccine Fluvac. Specifi cally, our results indicate that the lymphocytes responded to an antigen from infl uenza strain A/California/7/2009 that was present in the trivalent vaccine. Previous studies demonstrated that infl uenza A virus-specifi c CD8 + T lymphocytes persist for prolonged periods within the peripheral blood of adult subjects (18) (19) (20) . These observations corroborate our results, as we examined lymphocytes from subjects that were vaccinated against infl uenza after the swH1N1 epidemic and the production of an swH1N1-specifi c vaccine. Furthermore, as in these recent studies, we detected an IFN-γ-mediated recall response in lymphocytes after stimulation with a cognate antigen. Other studies of distinct populations have also demonstrated that vaccination to infl uenza provides longterm immunity; however, these studies typically evaluated cell frequencies or the levels of cytokine production by certain cell types such as IFN-γ + IL-2 + cells, TNF-α CD4 + T cells, CD107 + CD8 + T cells, and IFN-γ + CD49 + CD8 + T cells stimulated in the presence of infl uenza peptide antigens (21) .
Numerous studies have demonstrated that previous infl uenza vaccinations, as well as infection by seasonal infl uenza or other infl uenza virus strains, can generate antibodies and lymphocytes that are cross-reactive to another strain (22) (23) (24) . However, the results of our MTT-based cell viability analyses do not support the hypothesis that previous exposures to infl uenza antigens result in improved responses to other closely related infl uenza antigens. The infl uence of previous exposures on the response to infl uenza is likely more evident, however, when examining cell markers and cytokine levels. Because the immune response is influenced by sexual hormones (25) , we also compared the response of lymphocytes from males and females after stimulation with influenza antigens; however, nearly identical stimulation patterns were observed in the cells from both populations, indicating that gender does not infl uence the immune response to infl uenza. SwH1N1 infection and vaccination induce different patterns of cytokine production, depending on the disease severity or the type of antigen used (26) . We observed an increase in IL-10 production in the cells from the vaccinated group, compared to those from unvaccinated individuals, indicating that circulating cells that are reactive against infl uenza antigens are programed to produce IL-10 upon the second exposure to a specific antigen. By comparing IL-10 and IFN-γ production within each group, we observed a balance between the two cytokines in the vaccinated group, while the cells in the unvaccinated group produced higher levels of IFN-γ than IL-10. Meanwhile, cells from the unvaccinated group produced higher levels of IFN-γ in response to Fluvac than did the cells from the vaccinated group. CD4
+ T cells are an important source of IL-10, which is essential for regulatory T cell (Treg) biology, particularly natural CD4 + CD25 + Foxp3 + Treg (27) . In a previous study, there was an increase in the frequency of CD4 + CD25 + and CD4 + Foxp3 + cells in the peripheral blood, followed by an increase in the plasma levels of IL-10, of individuals vaccinated against different strains of infl uenza (28) . In addition, Yu et al detected elevated levels of IL-6 and IL-10 in the sera of patients with severe H1N1 infection during the 2009 epidemic. This increase in IL-10 production was also observed in the blood of subjects that were recently immunized with the H1N1 vaccine (29) , as well as in the pulmonary tissue of mice experimentally infected with infl uenza A/California/04/09 (30) (31) .
After examining the effects of Fluvac antigens, we used infl uenza CD8
+ -conserved peptides to investigate whether at least part of the observed response was generated against influenza A-specific antigens. Significant stimulation was observed in cells from the vaccinated group to the HA1, HA2, HA3, NA1, and NA2 peptides; however, there were no signifi cant differences in the levels of viability between the cells stimulated with distinct peptides. A recent study demonstrated that the variability observed in the response to infl uenza is not due to differences between antigens, but due to differences between individuals or groups of individuals. This fi nding indicates that previous exposures to particular antigens do not necessarily determine the response to another antigen (32) . As such, two conclusions can be drawn from our results obtained using infl uenza peptides: fi rst, the clonal response of lymphocytes generated in response to the monovalent vaccine can be rescued from the peripheral blood, even after a long period, using the trivalent vaccine; second, this clonal response is not specifi c to a particular epitope, as exposure to all HA and NA peptides tested induced a response. Other studies have recently shown that CD4 + and CD8 + T cells induced by exposure to seasonal infl uenza virus can cross-recognize internal peptides from H1N1. Such cross-reactive T cells might mediate a heterosubtypic immunity that confers protection against symptomatic illness in individuals lacking pre-existing humoral immunity to the pandemic virus (33) (34) . Indeed, Sridhar and collaborators (2012) detected high frequencies of crossreactive CD8
+ IFN-γ + IL-2 + T cells against live swH1N1 virus in individuals that were seronegative for swH1N1 (35) .
Our fi ndings indicate that H1N1-reactive blood circulating lymphocytes are prevalent within vaccinated but not unvaccinated individuals, independent of previous infection, from southern Brazil, where there is a high incidence of influenza infections, resulting in background immunity. Furthermore, they demonstrate that effector lymphocytes from vaccinated and unvaccinated individuals exhibit distinct cytokine production profi les. Specifi cally, upon re-exposure to infl uenza antigens, the lymphocytes from vaccinated individuals likely mediate a mild infl ammatory response that is regulated by IL-10. Conversely, the lymphocytes from unvaccinated individuals likely modulate a robust infl ammatory response via the elevated production of IFN-γ. Meanwhile, there are several limitations to this study. Most notably, the number of subjects tested in this study was relatively low. Following the H1N1 pandemic, many individuals were vaccinated, and it was therefore diffi cult to fi nd unvaccinated subjects. In addition, we were unable to examine a group of infected subjects, as there were no cases of H1N1 reported in the area studied, likely due to the high proportion of vaccinated individuals. However, the fi ndings of this study can be used to predict and design more effi cient strategies for infl uenza immunization and therapy by identifying by considering at-risk groups and endemic areas.
